Appropriate implantable cardioverter-defibrillator interventions in cardiac resynchronization therapy-defibrillator (CRT-D) patients undergoing device replacement: time to downgrade from CRT-D to CRT-pacemaker? Insights from real-world clinical practice in the DECODE CRT-D analysis.
Cardiac Resynchronization Therapy With or Without Defibrillation: A Long-Standing Debate.
Golzio PG, Bocchino PP, Bissolino A, Angelini F, Gravinese C, Frea S.
Cardiol Rev. 2022 Sep-Oct 01;30(5):221-233. doi: 10.1097/CRD.0000000000000388. Epub 2021 Mar 19.
Socio-economic analysis of cardiac resynchronization therapy.
Field ME, Sweeney MO.
J Interv Card Electrophysiol. 2006 Dec;17(3):225-36. doi: 10.1007/s10840-006-9079-4. Epub 2007 Mar 20.
Cardiac resynchronization therapy (CRT) device replacement considerations: upgrade or downgrade? A complex decision in the current clinical setting.
Nakou ES, Simantirakis EN, Kallergis EM, Nakos KS, Vardas PE.
Europace. 2017 May 1;19(5):705-711. doi: 10.1093/europace/euw317.
Predictors and outcomes of cardiac resynchronization therapy extended to the second generator.
Li X, Yang D, Kusumoto F, Shen WK, Mulpuru S, Zhou S, Liang J, Wu G, Yang M, Liu JQ, Friedman PA, Cha YM.
Heart Rhythm. 2017 Dec;14(12):1793-1800. doi: 10.1016/j.hrthm.2017.09.002. Epub 2017 Sep 14.
Ampere Hour as a Predictor of Cardiac Resynchronization Defibrillator Pulse Generator Battery Longevity: A Multicenter Study.
Ellis CR, Dickerman DI, Orton JM, Hassan S, Good ED, Okabe T, Andriulli JA, Quan KJ, Greenspon AJ.
Pacing Clin Electrophysiol. 2016 Jul;39(7):658-68. doi: 10.1111/pace.12831. Epub 2016 Mar 11.
Reduced appropriate implantable cardioverter-defibrillator therapy after cardiac resynchronization therapy-induced left ventricular function recovery: a meta-analysis and systematic review.
Chatterjee NA, Roka A, Lubitz SA, Gold MR, Daubert C, Linde C, Steffel J, Singh JP, Mela T.
Eur Heart J. 2015 Nov 1;36(41):2780-9. doi: 10.1093/eurheartj/ehv373. Epub 2015 Aug 10.
Cardiac resynchronization therapy improves myocardial conduction.
Yang M, Li X, Yang D, Li Y, Zhou S, Liang J, Wu G, Del-Carpio Munoz F, Chen HH, Friedman PA, Cha YM.
Pacing Clin Electrophysiol. 2019 Feb;42(2):238-246. doi: 10.1111/pace.13581. Epub 2018 Dec 27.
Mid-term feasibility and safety of downgrade procedure from defibrillator to pacemaker with cardiac resynchronization therapy.
Ogano M, Iwasaki YK, Tsuboi I, Kawanaka H, Tajiri M, Takagi H, Tanabe J, Shimizu W.
Int J Cardiol Heart Vasc. 2018 Dec 29;22:78-81. doi: 10.1016/j.ijcha.2018.12.012. eCollection 2019 Mar.
Battery longevity of implantable cardioverter-defibrillators and cardiac resynchronization therapy defibrillators: technical, clinical and economic aspects. An expert review paper from EHRA.
Boriani G, Merino J, Wright DJ, Gadler F, Schaer B, Landolina M.
Europace. 2018 Dec 1;20(12):1882-1897. doi: 10.1093/europace/euy066.
Economic impact of longer battery life of cardiac resynchronization therapy defibrillators in Sweden.
Gadler F, Ding Y, Verin N, Bergius M, Miller JD, Lenhart GM, Russell MW.
Clinicoecon Outcomes Res. 2016 Oct 31;8:657-666. doi: 10.2147/CEOR.S114921. eCollection 2016.
